Dr. Obinna Nnaemeka Eruchalu, MD

Dr. Eruchalu practices at Metrolina Surgical Specialists in Monroe, North Carolina.

Dr. Eruchalu's NPI, 1194788042, was assigned on April 11, 2006. Dr. Eruchalu holds North Carolina license 00-38331.

Dr. Eruchalu's primary practice is Metrolina Surgical Specialists, at 907 Fitzgerald St, Monroe, NC 28112 in Union County. The practice phone is (704) 226-0531.

Dr. Eruchalu's primary practice is Metrolina Surgical Specialists in Monroe, North Carolina. Dr. Eruchalu is also affiliated with Atrium Health Union. Dmand AI also links Dr. Eruchalu to 2 more hospitals and 1 physician office, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Eruchalu practices, 4 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Eruchalu's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Eruchalu is licensed in North Carolina.

CMS data shows 436 Medicare services from Dr. Eruchalu across 9 procedure codes in 2024, for 80 Medicare patients. Medicare paid $37,987 for them. Every service was in an office.

CMS counts 80 Medicare patients who saw Dr. Eruchalu in 2024. The largest group is 75 to 84, with 33 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 33% are also on Medicaid. Their average risk score is 2.88, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Eruchalu's median patient age at 67, with 55% women.

In 2024, Dr. Eruchalu wrote 143 Medicare Part D claims for 55 patients. 90% of them were for generic drugs. CMS names the drug for 98 of them, across 6 drugs with 11 or more claims each, at $13,965 in total drug cost. In 2023, CMS named 16 claims across 1 drug.

Dr. Eruchalu accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 18 procedures of leg revascularization (restoring blood flow) by Dr. Eruchalu, more than 77% of the clinicians it reports for that procedure.

Varicose vein removal: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 76 general payments to Dr. Eruchalu from 27 drug and device companies from 2016 to 2025. Device or supply loans make up the largest share, 76% of the total. AngioDynamics, Inc. paid the most, $10,804.